ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models | Icahn School of Medicine at Mount Sinai / Eirini Papapetrou, MD/PhD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2016 | New York |
Role of Inflammatory Microenvironment in Clonal evolution and Progression from FPD to AML | Oregon Health & Science University / Anupriya Agarwal, PhD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2017 | Oregon |
Restoring RUNX1 Levels in FPD/AML | University of Washington, Seattle / Marshall Horwitz, MD/PhD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2016 | Washington |
Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML | Boston Children’s Hospital / Alan Cantor, MD, PhD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2016 | Massachusetts |
Drug Screen for FPD/AML Therapeutics | Children’s Hospital of Philadelphia / Mortimer Poncz, MD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2017 | Pennsylvania |
Empowering specificity of AML immunotherapies by HSC engineering | Boston Children’s Hospital / Pietro Genovese | Catalyst Grants | 2023 | Massachusetts |
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma | Board of Trustees of the Leland Stanford Junior University / Michelle Monje | Catalyst Grants | 2021 | California |
Cell Line and Xenograft Repository | Texas Tech University Health Sciences Center / Patrick Reynolds, MD/PhD | Catalyst Grants | 2014 | Texas |
A Genomics Driven Pluripotent Stem Cell Model of Infant Lymphoblastic Leukemia | Children's Mercy Hospital Kansas City / Meagan Vacek, DO | Catalyst Grants | 2023 | Missouri |
Empowering specificity of AML immunotherapies by HSC engineering | Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Pietro Genovese | Catalyst Grants | 2023 | Georgia |